| Financial Year |
March 31 2023 |
| Monetary Funds |
2,060,567,210.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
501,795,531.35 |
| Advances to Suppliers |
326,422,412.01 |
| Other Receivables |
66,721,849.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,186,140,817.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
130,633,466.17 |
| Total Current Assets |
5,290,976,619.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,003,189.90 |
| Fixed Assetes |
4,491,768,073.83 |
| Under-construction Projects |
2,137,538,386.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
462,929,204.98 |
| R&D expenses |
-- |
| Goodwill |
43,422,947.03 |
| Long-Term Deferred and Prepaid Expenses |
4,286,782.46 |
| Deferred Income Tax Assets |
4,356,225.35 |
| Other Non-Current Assets |
42,378,164.18 |
| Sub-Total of Non-Current Assets |
7,208,476,502.84 |
| Total Assets |
12,499,453,122.57 |
| Short-Term Loans |
1,070,369,746.17 |
| Trading Financial liabilities |
599,610.00 |
| Notes Payable |
509,300,000.00 |
| Accounts Payable |
1,423,176,815.52 |
| Accounts Received In Advance |
177,743,002.67 |
| Employee Compensation Payable |
33,897,376.46 |
| Taxes Payable |
51,889,130.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,224,203.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
407,583,233.59 |
| Other Current Liabilities |
68,350,014.78 |
| Sub-Total of Current Liabilities |
4,372,880,550.71 |
| Long-term Loans |
866,938,565.84 |
| Bonds Payable |
890,038,727.12 |
| Long-Term Accounts Payable |
15,373,348.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,339,517.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,019,027,387.12 |
| Total Liabilities |
6,391,907,937.83 |
| Paid-In Capital(Or Share Stock) |
382,448,858.00 |
| Capital Surplus |
2,421,316,877.31 |
| Surplus Reserve |
144,818,899.66 |
| LESS:Treasury Stock |
79,143,128.11 |
| Undistributed Profits |
2,268,314,539.65 |
| Minority Stockholder's Interest |
820,797,839.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,286,747,345.46 |
| Owner's Equity（Stockholder's Equity） |
6,107,545,184.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,499,453,122.57 |
